Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 977,402 | 1,012,586 | 997,000 | 949,757 | 986,315 |
| Cost of Goods | 453,174 | 458,977 | 429,000 | 423,022 | 407,501 |
| Gross Profit | 524,227 | 553,610 | 568,000 | 526,735 | 578,814 |
| Operating Expenses | 364,936 | 353,187 | 363,000 | 329,510 | 358,419 |
| Operating Income | 159,466 | 201,400 | 205,000 | 197,247 | 220,896 |
| Interest Expense | 10,573 | 10,431 | 10,000 | 7,339 | 9,652 |
| Other Income | 23,912 | 20,056 | 28,000 | 34,849 | 9,912 |
| Pre-tax Income | 172,805 | 211,025 | 223,000 | 224,757 | 221,156 |
| Income Tax | 39,570 | 46,943 | 58,000 | 46,044 | 55,507 |
| Net Income Continuous | 133,235 | 164,082 | 165,000 | 178,713 | 165,648 |
| Minority Interests | -2,262 | -1,196 | -1,000 | -1,137 | -1,121 |
| Net Income | $135,498 | $165,278 | $166,000 | $179,850 | $166,769 |
| EPS Basic Total Ops | 0.16 | 0.20 | 0.20 | 0.35 | 0.20 |
| EPS Basic Continuous Ops | 0.16 | 0.20 | 0.20 | 0.37 | 0.20 |
| EPS Diluted Total Ops | 0.16 | 0.20 | 0.20 | 0.35 | 0.20 |
| EPS Diluted Continuous Ops | 0.16 | 0.20 | 0.20 | 0.37 | 0.20 |
| EPS Diluted Before Non-Recurring Items | 0.16 | 0.19 | 0.20 | 0.22 | 0.20 |
| EBITDA(a) | $215,466 | $256,400 | $261,000 | $251,247 | $273,896 |